
A $1.1-million NSF grant awarded to Advanced Polymer Monitoring Technologies will be used for the development of a characterization technology for monitoring aggregation in biopharmaceuticals.
A $1.1-million NSF grant awarded to Advanced Polymer Monitoring Technologies will be used for the development of a characterization technology for monitoring aggregation in biopharmaceuticals.
The advanced capillary electrophoresis system, Maurice, from ProteinSimple is used for the quantitative analysis of identity, purity, and heterogeneity profiles of biopharmaceuticals.
Researchers describe a new method to compare the higher-order structure of a reference biologic with its proposed biosimilar product candidates.
Time and sensitivity are essential for analytical technologies in all phases of biopharma development.
The company’s new version of its glycan analysis tool will help investigators determine the relative abundance of individual N-glycan structures in small biopharmaceutical samples.
GEA’s Panther NS3006L high-pressure homogenizer is a standalone unit designed to reduce particle size to nanometer ranges.
Liquid particle counters are ideal for protein aggregation studies.
TOC Analyzer Increases Productivity
Handheld Analyzer Improves Accuracy
SEC-MALS Detector for UHPLC
The ?DAWN can be attached to any UHPLC system to determine molecular weights and sizes of proteins.
The Sievers M9 TOC Analyzer enhances productivity.
Line of Environmental Measurement Products
UPLC Separation Intergrates into Mass Spectrometers
High-Performance Separation-Electrospray Ionization System
Mass Spectrometer Enhances Performance in Protein Analysis
Liquid Chromatography Column Separates Glycans
Aggregation System Improves Analysis of Sub-Visible Particles
The Waters ACQUITY QDa Detector is a mass detector designed to bring high-quality, mass spectral data to chromatographic separations.
Rigaku Raman Technologies announced an updated version of the FirstGuard handheld Raman analyzer at Pittcon 2013.
As biopharmaceutical/pharmaceutical companies increase their development of biologic-based drugs, companies providing analytical instrumentation and laboratory testing goods and services are, in turn, offering improved tools for biologic characterization, biomanufacturing, and related testing.